1
|
Gibson L, Mittal A, Qureshi F, Neerumpa S, Hamidpour S, Mateescu V, Salzman G, Molteni A, Monaghan NP, Poisner A. Distinct Responses in the Brain Compared to Lung in a Rat Model of Fat Embolism Syndrome. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.r4079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Lilian Gibson
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - A. Mittal
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - F. Qureshi
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - S. Neerumpa
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - S. Hamidpour
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - V. Mateescu
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - G. Salzman
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | - A. Molteni
- Biomedical sciencesUniversity of MissouriKansas CityMO
| | | | - A. Poisner
- University of Kansas Medical CenterKansas CityKS
| |
Collapse
|
2
|
Siddiqui G, Hamidpour S, Mateescu V, Monaghan Nichols P, Wacker M, Poisner A, Salzman G, Molteni A. Cardiac and pulmonary expression of renin, prorenin, mast cells and macrophages in a rat model of fat embolism syndrome. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.r2228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Gulnaz Siddiqui
- Department of biomedical sciencesUniversity of MissouriKansas CityMO
| | | | | | | | - Michael Wacker
- Department of biomedical sciencesUniversity of MissouriKansas CityMO
| | - Alan Poisner
- PharmacologyKansas University Medical CenterKansas CityKS
| | - Gary Salzman
- University Health Kansas City HospitalKansas CityMO
| | - Agostino Molteni
- Department of biomedical sciencesUniversity of MissouriKansas CityMO
| |
Collapse
|
3
|
Wamkpah N, Shrestha A, Salzman G, Simon S, Suman S, Poisner A, Molteni A. Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease. Cureus 2022; 14:e23567. [PMID: 35494947 PMCID: PMC9045847 DOI: 10.7759/cureus.23567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/27/2022] [Indexed: 11/30/2022] Open
Abstract
Rationale Acute chest syndrome (ACS) is a life-threatening complication of sickle cell disease (SCD). Current treatment is supportive-supplemental oxygen, transfusions, and antibiotics. Prevention of ACS may reduce morbidity and mortality in patients with SCD. Acute chest syndrome appears similar to pulmonary fat embolism (PFE), a complication of severe skeletal trauma or orthopedic procedures from pulmonary micro-vessel blockage by bone marrow fat. Vascular obstruction and bone marrow necrosis occur in PFE and ACS. Pulmonary fat embolism rat models have shown that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) mitigate damage in PFE. These medications could work similarly in ACS. We hypothesize that time to readmission after one hospitalization for ACS will be reduced in patients taking ACEI or ARB compared to patients who are not. Methods This is a retrospective cohort study. Inclusion criteria are adults (18 to 100 years) with sickle cell anaemia (HbSS), hemoglobin SC (HbSC) disease, sickle cell thalassemia (HbSβThal), hospitalized with ACS over 16 years (January 1, 2000, to March 31, 2016); patients who take and don’t take ACEI or ARB. Children (<18 years old), elderly adults (>100 years old), pregnant patients, and patients with sickle cell trait were excluded. Data was collected from the Health Facts database, which contains de-identified information from the electronic medical records of hospitals in which Cerner© has a data use agreement. Kaplan-Meier estimates explored a time-to-event model of ACS readmission. Multivariable analysis (age, gender, smoking history) was conducted using Cox proportional hazards regression. Results were reported around a 95% confidence interval. Results There were 6972 patients in total. Of which, 9.6% (n = 667) reported taking ACEI or ARB. Results for the covariates were: average age of 38 years old; 63% female (n = 4366/6969); 16% smokers (n = 1132). Readmission rates were higher for patients not taking ACEI/ARB than those who did: 0.44 (95% CI 0.43, 0.46) versus 0.28 (95% CI 0.24, 0.31) at one year, and 0.56 (95% CI 0.55, 0.58) versus 0.33 (95% CI 0.29, 0.37) at two years. Age had the strongest effect on readmission rates for patients taking ACEI/ARB (adjusted hazards ratio 0.78 [95% CI 0.68, 0.91]). Conclusion Patients with SCD who reported taking ACEI or ARB had lower readmission rates for ACS; age was the strongest covariate. Our results may have a significant impact on the prevention of ACS. Prospective studies comparing ACEI or ARB therapy versus placebo are needed to confirm this preventative effect.
Collapse
|
4
|
Passalacqua R, Ratti M, Pan A, Testa S, Molteni A, Tonoli S, Faliva A, Mainardi E, Saleri J, Gobbi A, Nanni N, Bacciocchini N, Donati G, Marchi R, Cattaneo M, Gnocchi N, Grizzi G, Brighenti M, Maglietta G, Caminiti C. 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial). Ann Oncol 2021. [PMCID: PMC8454316 DOI: 10.1016/j.annonc.2021.08.1639] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
5
|
F. VanDillen A, Vandillen M, Hamidpour S, Mateescu V, Silswal N, Wacker M, Patel S, Vallejo J, Ahuja R, Monaghan‐Nichols P, Salzman G, Poisner A, Molteni A. Absence of Cardiac Immune Pathology in a Rat Model of Fat Embolism Syndrome. FASEB J 2021. [DOI: 10.1096/fasebj.2021.35.s1.00247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Soheila Hamidpour
- University of Missouri‐Kansas City School of Medicine/ Truman Medical CentersKansas CityMO
| | - Valerica Mateescu
- PathologyUniversity of Missouri Kansas City/Truman Medical CentersKansas CityMO
| | - Neerupma Silswal
- Department of Biomedical SciencesSchool of Medicine, University of Missouri Kansas CityKansas CityMO
| | - Michael Wacker
- University of Missouri‐Kansas City School of MedicineKansas CityMO
| | - Shaan Patel
- University of Missouri‐Kansas City School of MedicineKansas CityMO
| | - Julian Vallejo
- University of Missouri‐Kansas City School of MedicineKansas CityMO
| | - Rohan Ahuja
- University of Missouri‐Kansas City School of MedicineKansas CityMO
| | - Paula Monaghan‐Nichols
- Professor and Chair Biomedical SciencesSchool of Medicine, University of Missouri in Kansas CityKansas CityMO
| | - Gary Salzman
- University of Missouri‐Kansas City School of MedicineKansas CityMO
| | | | - Agostino Molteni
- PathologySchool of Medicine, University of Missouri in Kansas CityKansas CityMO
| |
Collapse
|
6
|
Wacker MJ, Patel S, Vallejo J, Colson J, Edegbe J, Lin J, Salzman G, Poisner A, Monaghan AP, Molteni A. Cardiac Gene Expression and Histology in a Rat Model of Fat Embolism. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.03151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Shaan Patel
- University of Missouri-Kansas City School of Medicine
| | | | - Jordan Colson
- University of Missouri-Kansas City School of Medicine
| | - Joy Edegbe
- University of Missouri-Kansas City School of Medicine
| | - Jane Lin
- University of Missouri-Kansas City School of Medicine
| | - Gary Salzman
- University of Missouri-Kansas City School of Medicine
| | | | | | | |
Collapse
|
7
|
Qureshi F, Colson J, Al-Husseinawi E, Silswal N, Tianhua L, Salzman GA, Poisner A, Nichols APM, Molteni A. Long term Impact of Fat emboli in a Rat Model of Fat Embolism Syndrome. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.05568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
8
|
Khalafi F, Randall Z, Leupold B, Silswal N, Monaghan P, Poisner A, Molteni A. Aliskiren Effect on Kidney Renin‐Prorenin Stained Cells in a Rat Model for Fat Embolism. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.496.61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Al‐Husseinawi EK, Colson J, Siddiqi A, Arif D, Alallaf J, Montgomery C, Randall Z, Johnson H, Koulen P, Poisner A, Monaghan P, Molteni A. The Presence of Fat Droplets in the Retina of Rats in a Model of Fat Embolism. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.496.67] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
10
|
Colson JD, Siddiqi A, Van Dillen M, Fotouhi A, Al‐Husseinawi E, Al‐Allaf J, Wells B, Monaghan P, Poisner A, Molteni A. Fat Emboli in the Rat Brain in a Model of Fat Embolism Syndrome. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.802.56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Ahsan Siddiqi
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | | | | - Jwan Al‐Allaf
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | - Paula Monaghan
- Biomedical SciencesUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | |
Collapse
|
11
|
Lin JH, Egdebe J, Hamidpour S, Omoscharka E, Haferkamp T, Lind T, Spaedy A, Silswal N, Pour M, Poisner A, Moneghan P, Molteni A. Mast Cells and Macrophages of Rats lungs in an Acute Model of Fat Embolism. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.802.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Joy Egdebe
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | | | | - Taylor Lind
- University of Missouri‐Kansas CityKansas CityMO
| | | | - Neerupma Silswal
- Basic Medical SciencesUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | | - Paula Moneghan
- Basic Medical SciencesUniversity of Missouri‐Kansas CityKansas CityMO
| | | |
Collapse
|
12
|
Siddiqi A, Fotouhi A, Vandillen M, Fotouhi A, Silswal N, Arif D, Poisner A, Monaghan P, Molteni A. Fat Emboli in the Rat Aorta in a Model of Fat Embolism Syndrome. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.lb10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ahsan Siddiqi
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | | | | - Neerupma Silswal
- Biomedical SciencesUniversity of Missouri‐Kansas CityKansas CityMO
| | - Dauod Arif
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | - Paula Monaghan
- Biomedical SciencesUniversity of Missouri‐Kansas CityKansas CityMO
| | | |
Collapse
|
13
|
Coulibaly FS, Ezoulin MJM, Dim DC, Molteni A, Youan BBC. Preclinical Safety Evaluation of HIV-1 gp120 Responsive Microbicide Delivery System in C57BL/6 Female Mice. Mol Pharm 2019; 16:595-606. [PMID: 30525661 DOI: 10.1021/acs.molpharmaceut.8b00872] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Many novel vaginal/rectal microbicide formulations failed clinically due to safety concerns, indicating the need for the early investigation of lead microbicide formulations. In this study, the preclinical safety of an HIV-1 gp120 and mannose responsive microbicide delivery system (MRP) is evaluated in C57BL/6 mice. MRP was engineered through the layer-by-layer coating of calcium carbonate (CaCO3) with Canavalia ensiformis lectin (Con A) and glycogen. MRP mean particle diameter and zeta potential were 857.8 ± 93.1 nm and 2.37 ± 4.12 mV, respectively. Tenofovir (TFV) encapsulation and loading efficiencies in MRP were 70.1% and 16.3% w/w, respectively. When exposed to HIV-1 rgp120 (25 μg/mL), MRP released a significant amount of TFV (∼5-fold higher) in vaginal and seminal fluid mixture compared to the control (pre-exposure) level (∼59 μg/mL) in vaginal fluid alone. Unlike the positive control treated groups (e.g., nonoxynol-9), no significant histological damages and CD45+ cells infiltration were observed in the vaginal and major reproductive organ epithelial layers. This was probably due to MRP biocompatibility and its isosmolality (304.33 ± 0.58 mOsm/kg). Furthermore, compared to negative controls, there was no statistically significant increase in pro-inflammatory cytokines such as IL1α, Ilβ, IL7, IP10, and TNFα. Collectively, these data suggest that MRP is a relatively safe nanotemplate for HIV-1 gp120 stimuli responsive vaginal microbicide delivery system.
Collapse
Affiliation(s)
- Fohona S Coulibaly
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy , University of Missouri-Kansas City , 2464 Charlotte , Kansas City , Missouri 64108 , United States
| | - Miezan J M Ezoulin
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy , University of Missouri-Kansas City , 2464 Charlotte , Kansas City , Missouri 64108 , United States
| | - Daniel C Dim
- School of Medicine , University of Missouri-Kansas City School of Medicine , Kansas City , Missouri 64108 , United States
| | - Agostino Molteni
- School of Medicine , University of Missouri-Kansas City School of Medicine , Kansas City , Missouri 64108 , United States
| | - Bi-Botti C Youan
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy , University of Missouri-Kansas City , 2464 Charlotte , Kansas City , Missouri 64108 , United States
| |
Collapse
|
14
|
Poisner A, Bass D, Fletcher A, Jain A, England JP, Davis MG, Arif D, Molteni A. Evidence for angiotensin mediation of the late histopathological effects of pulmonary fat embolism: Protection by losartan in a rat model. Exp Lung Res 2019; 44:361-367. [PMID: 30638089 DOI: 10.1080/01902148.2018.1552339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
PURPOSE In a model of fat embolism using triolein-treated rats, we have reported that the acute pulmonary histopathological changes at 48 hrs were ameliorated by the angiotensin AT1 receptor blocker losartan, the angiotensin converting enzyme inhibitor captopril, and the direct renin inhibitor aliskiren. Although much of the pathology had declined by 3 weeks, the changes persisted at 6 weeks. The purpose of the study was to extends the time course investigation to 10 weeks and to examines whether the fat embolism effects continue to be blocked by losartan when given at a late time period. MATERIALS AND METHODS Unanesthetized rats were challenged with i.v. triolein or saline. After 6 weeks, one group received saline or losartan i.p. and the losartan group also received losartan in the drinking water. At 10 weeks, the experiment was terminated. RESULTS Confirming previous results, the fat embolism group showed normal weight gain at 6 weeks without apparent distress and also appeared normal at 10 weeks. However, at 10 weeks the lungs showed inflammatory and fibrotic changes that were greater than those found at 6 weeks. These changes were reduced by losartan. CONCLUSIONS These findings show that the effects of fat embolism continue to progress to 10 weeks after the initial insult with triolein. The fact that the protective effects of losartan treatment started at 6 weeks supports the involvement of the renin-angiotensin system in late as well as early stages of the histopathological changes following fat embolism. It also supports the use of angiotensin blockade in clinical situations even long after an initial trauma where fat embolism is suspected.
Collapse
Affiliation(s)
- Alan Poisner
- a 1 Department of Pharmacology , University of Kansas Medical Center, Kansas City, KS, USA.,b Pharmacology , University of Kansas Medical Center , Kansas City , KS, USA
| | - Devin Bass
- c Pathology , University of Missouri Kansas City School of Medicine , Kansas City , MO, USA
| | - Amanda Fletcher
- d University of Missouri Kansas City School of Medicine , Kansas City , MO, United States
| | - Ashwin Jain
- d University of Missouri Kansas City School of Medicine , Kansas City , MO, United States
| | | | - Mariah Gawlik Davis
- d University of Missouri Kansas City School of Medicine , Kansas City , MO, United States
| | - Dauod Arif
- c Pathology , University of Missouri Kansas City School of Medicine , Kansas City , MO, USA
| | - Agostino Molteni
- e Pathology , University of Missouri Kansas City , Kansas City , MO, USA
| |
Collapse
|
15
|
Colson J, Arif D, Voelker D, Spaedy A, Hamidpour S, Poisner A, Pour M, Monaghan P, Khalafi F, Molteni A. MAST CELL NUMBERS OF RAT LUNGS IN AN ACUTE MODEL OF FAT EMBOLISM ARE REDUCED BY ALISKIREN AND LOSARTAN BUT NOT BY CAPTOPRIL. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.817.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Jordan Colson
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Dauod Arif
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | | | | - Alan Poisner
- PharmcologyKansas University Medical CenterKansas CityKS
| | | | | | - Farnaz Khalafi
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | |
Collapse
|
16
|
Khalafi F, Onishchenko E, Pour M, Arif D, Monaghan P, Poisner A, Molteni A. MINIMAL EFFECT OF ALISKIREN ON MAST CELLS COUNT AND RENAL VASCULAR DAMAGE IN ACUTE RAT MODEL OF TRIOLEIN INDUCED PULMONARY FAT EMBOLISM. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.676.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Mohammad Pour
- University of Kansas School of MedicineKansas CityKS
| | | | | | - Alan Poisner
- PharmacologyUniversity of Kansas School of MedicineKansas CityKS
| | | |
Collapse
|
17
|
Al‐Husseinawi E, Colson JD, Van Dillen M, Fotouhi A, Asan M, White L, Pour M, Arif D, Monaghan P, Poisner A, Molteni A. PULMONARY CELL STAINED IN A RAT MODEL OF FAT EMBOLISM FOR RENIN AND PRORENIN ARE INCREASED AFTER ALISKIREN TREATMENT, WHICH AMELIORATES THE FAT‐INDUCED INFLAMMATORY PROCESS. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.818.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | | | | | | | | | | | - Dauod Arif
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Paula Monaghan
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | | |
Collapse
|
18
|
Siddiqi A, Hamdan H, Siddiqi S, Pour M, Randall Z, Leupold B, Arif D, Poisner A, Hamidpour S, Molteni A. Mast Cell Numbers In Rat Livers In An Acute Model Of Fat Embolism Are Reduced By Losartan But Not By Captopril. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.lb554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ahsan Siddiqi
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Hana Hamdan
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Saba Siddiqi
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Mohammad Pour
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | - Brad Leupold
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Dauod Arif
- PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Alan Poisner
- PharmacologyUniversity of Kansas Medical CenterKansas CityKS
| | | | | |
Collapse
|
19
|
Siddiqi A, Siddiqi S, Arif D, Haferkamp T, Lind T, Poisner A, Pour M, Monaghan P, Hamidpour S, Molteni A. MAST CELL HETEROGENEITY IN RAT LUNGS IN A MODEL OF FAT EMBOLISM AFTER TREATMENT WITH DRUGS RELATED TO THE RENIN ANGIOTENSIN SYSTEM. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.676.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Dauod Arif
- University of Missouri‐Kansas CityKansas CityMO
| | | | - Taylor Lind
- University of Missouri‐Kansas CityKansas CityMO
| | | | | | | | | | | |
Collapse
|
20
|
Arif D, Colson J, Al‐Husseinawi E, Khalafi F, Ponnapureddy R, Pour M, Silswal N, Mudar I, Leupold B, Poisner A, Molteni A. Renin and Prorenin Stained Cells in the Hearts of Rats Subjected to Fat Embolism and Treated with Aliskiren, a Drug Ameliorating the Pulmonary Inflammatory Process. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.lb583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Dauod Arif
- Department of PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | - Jordan Colson
- Department of PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | - Farnaz Khalafi
- Department of PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| | | | - Mohammad Pour
- Department of MedicineUniversity of Missouri‐Kansas CityKansas CityMO
| | - Neerupma Silswal
- Department of MedicineUniversity of Missouri‐Kansas CityKansas CityMO
| | - Ismail Mudar
- Department of MedicineUniversity of Missouri‐Kansas CityKansas CityMO
| | - Bradley Leupold
- Department of MedicineUniversity of Missouri‐Kansas CityKansas CityMO
| | - Alan Poisner
- PharmcologyKansas University Medical CenterKansas CityKS
| | - Agostino Molteni
- Department of PathologyUniversity of Missouri‐Kansas CityKansas CityMO
| |
Collapse
|
21
|
Voso MT, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, Criscuolo M, Masciulli A, Cerqui E, Molteni A, Finelli C, Parma M, Poloni A, Carella AM, Spina F, Cortelezzi A, Salvi F, Alessandrino EP, Rambaldi A, Sica S. Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study. Ann Oncol 2018; 28:1547-1553. [PMID: 28368509 DOI: 10.1093/annonc/mdx154] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2017] [Indexed: 12/25/2022] Open
Abstract
Background Allogeneic stem-cell transplantation (HSCT) is the only curative treatment in myelodysplastic syndromes (MDS). Azacitidine (AZA) is increasingly used prior to HSCT, however in Europe it is only approved for patients who are not eligible for HSCT. Patients and methods We conducted a phase II multicenter study to prospectively evaluate the feasibility of HSCT after treatment with AZA in 70 patients with a myelodysplastic syndrome (MDS), 19 with acute myeloid leukemia (AML), and 8 with chronic myelomonocytic leukemia (CMML). After a median of four cycles (range 1-11): 24% of patients achieved complete remission, 14% partial remission, 8% hematologic improvement, 32% had stable and 22% progressive disease. Ten patients discontinued treatment before the planned four cycles, due to an adverse event in nine cases. Results A HSC donor was identified in 73 patients, and HSCT was performed in 54 patients (74% of patients with a donor). Main reasons for turning down HSCT were lack of a donor, an adverse event, or progressive disease (9, 12, and 16 patients, respectively). At a median follow-up of 20.5 months from enrolment, response to AZA was the only independent prognostic factor for survival. Compared to baseline assessment, AZA treatment did not affect patients' comorbidities at HSCT: the HCT-CI remained stable in 62% patients, and worsened or improved in 23% and 15% of patients, respectively. Conclusions Our study shows that HSCT is feasible in the majority of patients with HR-MDS/AML/CMML-2 after AZA treatment. As matched unrelated donor was the most frequent source of donor cells, the time between diagnosis and HSCT needed for donor search could be 'bridged' using azacitidine. These data show that AZA prior to HSCT could be a better option than intensive chemotherapy in higher-risk MDS. The trial has been registered with the EudraCT number 2010-019673-1.
Collapse
Affiliation(s)
- M T Voso
- Division of Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome
| | - G Leone
- Department of Hematology, Università Cattolica del Sacro Cuore, Rome
| | - A Piciocchi
- Department of Statistical Sciences, La Sapienza University, Rome
| | - L Fianchi
- Department of Hematology, Università Cattolica del Sacro Cuore, Rome
| | - S Santarone
- Department of Hematology, Centro Trapianti Midollo Osseo, Pescara
| | - A Candoni
- Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine
| | - M Criscuolo
- Department of Hematology, Università Cattolica del Sacro Cuore, Rome
| | - A Masciulli
- Department of Hematology, ASST Papa Giovanni XXIII, Bergamo
| | - E Cerqui
- Department of Hematology, A.O. Spedali Civili, Brescia
| | - A Molteni
- Department of Hematology, Ospedale Niguarda, Milano
| | - C Finelli
- Department of Hematology, Ospedale Sant'Orsola Malpighi, University of Bologna, Bologna
| | - M Parma
- Department of Hematology, HSCT Adult Unit, San Gerardo Hospital, Monza
| | - A Poloni
- Department of Hematology, Azienda Ospedaliera Universitaria - Ospedali Riuniti di Ancona, Ancona
| | - A M Carella
- Department of Hematology, Ospedale Opera Padre Pio, San Giovanni Rotondo
| | - F Spina
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
| | - A Cortelezzi
- Department of Hematology Oncology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milano
| | - F Salvi
- Department of Hematology, "SS Antonio e Biagio" Hospital, Alessandria
| | - E P Alessandrino
- Department of Hematology, Policlinico San Matteo and Pavia University, Pavia, Italy
| | - A Rambaldi
- Department of Hematology, ASST Papa Giovanni XXIII, Bergamo
| | - S Sica
- Department of Hematology, Università Cattolica del Sacro Cuore, Rome
| |
Collapse
|
22
|
Meng J, Agrahari V, Ezoulin MJ, Purohit SS, Zhang T, Molteni A, Dim D, Oyler NA, Youan BBC. Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery. AAPS J 2017; 19:692-702. [PMID: 28138910 DOI: 10.1208/s12248-016-0007-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Accepted: 10/12/2016] [Indexed: 12/25/2022] Open
Abstract
It is hypothesized that novel thiolated chitosan-coated multilayer microparticles (MPs) with enhanced drug loading are more mucoadhesive than uncoated MPs and safe in vivo for vaginal delivery of topical anti-HIV microbicide. Formulation optimization is achieved through a custom experimental design and the alginate (AG) MPs cores are prepared using the spray drying method. The optimal MPs are then coated with the thiolated chitosan (TCS) using a layer-by-layer method. The morphological analysis, in situ drug payload, in vitro drug release profile, and mucoadhesion potential of the MPs are carried out using scanning electron microscopy, solid-state 31P NMR spectroscopy, UV spectroscopy, fluorescence imaging and periodic acid Schiff method, respectively. The cytotoxicity and preclinical safety of MPs are assessed on human vaginal (VK2/E6E7) and endocervical (End1/E6E7) epithelial cell lines and in female C57BL/6 mice, respectively. The results show that the MPs are successfully formulated with an average diameter ranging from 2 to 3 μm with a drug loading of 7-12% w/w. The drug release profile of these MPs primarily follows the Baker-Lonsdale and Korsmeyer-Peppas models. The MPs exhibit high mucoadhesion (20-50 folds) compared to native AGMPs. The multilayer MPs are noncytotoxic. Histological and immunochemical analysis of the mice genital tract shows neither signs of damage nor inflammatory cell infiltrate. These data highlight the potential use of TCS-coated AG-based multilayer MPs templates for the topical vaginal delivery of anti-HIV/AIDS microbicides.
Collapse
Affiliation(s)
- Jianing Meng
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA
| | - Vivek Agrahari
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA
| | - Miezan J Ezoulin
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA
| | - Sudhaunshu S Purohit
- Department of Chemistry, University of Missouri-Kansas City, Kansas City, Missouri, 64110, USA
| | - Tao Zhang
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA
| | - Agostino Molteni
- School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA
| | - Daniel Dim
- School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA
| | - Nathan A Oyler
- Department of Chemistry, University of Missouri-Kansas City, Kansas City, Missouri, 64110, USA
| | - Bi-Botti C Youan
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA.
| |
Collapse
|
23
|
Agrahari V, Meng J, Ezoulin MJM, Youm I, Dim DC, Molteni A, Hung WT, Christenson LK, Youan BBC. Stimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activity. Nanomedicine (Lond) 2016; 11:2935-2958. [PMID: 27785967 PMCID: PMC9816923 DOI: 10.2217/nnm-2016-0103] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
AIM To develop a seminal enzyme bioresponsive, mucoadhesive nanofibers (NFs) as safe and effective nanocarriers for the prevention of HIV vaginal transmission. METHODS A novel thiolated hyaluronic acid (HA-SH) polymer was synthesized to fabricate tenofovir (TFV)-loaded electrospun NFs (HA-SH-NFs) and characterized in vitro/in vivo. RESULTS A triggered drug release (87% w/w) from the engineered HA-SH-NFs (mean diameter ∼75 nm) occured within 1 h under the influence of seminal hyaluronidase enzyme. HA-SH-NFs were noncytotoxic, induced no damage on the C57BL/6 mice genital-tract and other organs. No significant CD45 cell-infiltration and changes in cytokines level in cervicovaginal tissues were observed. HA-SH-NFs significantly enhanced both TFV retention and bioavailability in vaginal tissue compared with the 1% TFV-gel. The anti-HIV activity of TFV (on pseudotyped virus followed by luciferase assay) was not adversely affected by the electrospinning process. CONCLUSION HA-SH-NFs developed in this study could potentially serve as a safe nanotemplate for topical intravaginal delivery of HIV/AIDS microbicides.
Collapse
Affiliation(s)
- Vivek Agrahari
- Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA
| | - Jianing Meng
- Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA
| | - Miezan JM Ezoulin
- Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA
| | - Ibrahima Youm
- Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA,Hough Ear Institute, Oklahoma City, OK 73112, USA
| | - Daniel C Dim
- School of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA
| | - Agostino Molteni
- School of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA
| | - Wei-Ting Hung
- Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| | - Lane K Christenson
- Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| | - Bi-Botti C Youan
- Laboratory of Future Nanomedicines & Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA,*Author for correspondence:
| |
Collapse
|
24
|
Meng J, Agrahari V, Ezoulin MJ, Zhang C, Purohit SS, Molteni A, Dim D, Oyler NA, Youan BBC. Tenofovir Containing Thiolated Chitosan Core/Shell Nanofibers: In Vitro and in Vivo Evaluations. Mol Pharm 2016; 13:4129-4140. [PMID: 27700124 DOI: 10.1021/acs.molpharmaceut.6b00739] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
It is hypothesized that thiolated chitosan (TCS) core/shell nanofibers (NFs) can enhance the drug loading of tenofovir, a model low molecular weight and highly water-soluble drug molecule, and improve its mucoadhesivity and in vivo safety. To test this hypothesis, poly(ethylene oxide) (PEO) core with TCS and polylactic acid (PLA) shell NFs are fabricated by a coaxial electrospinning technique. The morphology, drug loading, drug release profiles, cytotoxicity and mucoadhesion of the NFs are analyzed using scanning and transmission electron microscopies, liquid chromatography, cytotoxicity assays on VK2/E6E7 and End1/E6E7 cell lines and Lactobacilli crispatus, fluorescence imaging and periodic acid colorimetric method, respectively. In vivo safety studies are performed in C57BL/6 mice followed by H&E and immunohistochemical (CD45) staining analysis of genital tract. The mean diameters of PEO, PEO/TCS, and PEO/TCS-PLA NFs are 118.56, 9.95, and 99.53 nm, respectively. The NFs exhibit smooth surface. The drug loading (13%-25%, w/w) increased by 10-fold compared to a nanoparticle formulation due to the application of the electrospinning technique. The NFs are noncytotoxic at the concentration of 1 mg/mL. The PEO/TCS-PLA core/shell NFs mostly exhibit a release kinetic following Weibull model (r2 = 0.9914), indicating the drug release from a matrix system. The core/shell NFs are 40-60-fold more bioadhesive than the pure PEO based NFs. The NFs are nontoxic and noninflammatory in vivo after daily treatment for up to 7 days. Owing to their enhanced drug loading and preliminary safety profile, the TCS core/shell NFs are promising candidates for the topical delivery of HIV/AIDS microbicides such as tenofovir.
Collapse
Affiliation(s)
- Jianing Meng
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics Division of Pharmaceutical Sciences, University of Missouri-Kansas City , Kansas City, Missouri 64108, United States
| | - Vivek Agrahari
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics Division of Pharmaceutical Sciences, University of Missouri-Kansas City , Kansas City, Missouri 64108, United States
| | - Miezan J Ezoulin
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics Division of Pharmaceutical Sciences, University of Missouri-Kansas City , Kansas City, Missouri 64108, United States
| | - Chi Zhang
- Department of Chemistry, University of Missouri-Kansas City , Kansas City, Missouri 64110, United States
| | - Sudhaunshu S Purohit
- Department of Chemistry, University of Missouri-Kansas City , Kansas City, Missouri 64110, United States
| | - Agostino Molteni
- School of Medicine, University of Missouri-Kansas City , Kansas City, Missouri 64108, United States
| | - Daniel Dim
- School of Medicine, University of Missouri-Kansas City , Kansas City, Missouri 64108, United States
| | - Nathan A Oyler
- Department of Chemistry, University of Missouri-Kansas City , Kansas City, Missouri 64110, United States
| | - Bi-Botti C Youan
- Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics Division of Pharmaceutical Sciences, University of Missouri-Kansas City , Kansas City, Missouri 64108, United States
| |
Collapse
|
25
|
Patel C, Alqalyoobi S, Naji D, Herndon B, Poisner A, Molteni A. Coronary Arteries Injury in a Model of Pulmonary Fat Embolism Syndrome (PES). FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.610.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Chirag Patel
- Pathology/Medicine University of Missouri‐Kansas CityKansas CityMissouriUnited States
| | | | - Darwish Naji
- Pathology/Medicine University of Missouri‐Kansas CityKansas CityMissouriUnited States
| | - Betty Herndon
- Pathology/Medicine University of Missouri‐Kansas CityKansas CityMissouriUnited States
| | - Alan Poisner
- PharmacologyUniversity of Kansas Medical CenterKansas CityKansasUnited States
| | - Agostino Molteni
- Pathology/Medicine University of Missouri‐Kansas CityKansas CityMissouriUnited States
| |
Collapse
|
26
|
Kapuria D, Herndon B, Molteni A. Glucotoxicity Caused by Change in Hepatic Metabolic Pathways Leading to Type 2 Diabetes. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.767.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Devika Kapuria
- Dept. of Internal Medicine UMKC‐MO 2411 HolmesKansas CityMOUnited States
| | - Betty Herndon
- Dept. of Internal Medicine UMKC‐MO 2411 HolmesKansas CityMOUnited States
| | - Agostino Molteni
- Dept. of Pathology UMKC‐MO 2411 HolmesKansas CityMOUnited States
| |
Collapse
|
27
|
Haldiman L, Glazyrin A, Herndon B, Kapuria D, Molteni A. Maspin Expression of Pancreatic Inflammation in an Obese Strain of Mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.767.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Lindsey Haldiman
- Pathology and Laboratory MedicineUniversity of Missouri‐Kansas City School of MedicineKansas CityMOUnited States
| | - Alexey Glazyrin
- Pathology and Laboratory MedicineUniversity of Missouri‐Kansas City School of MedicineKansas CityMOUnited States
| | - Betty Herndon
- Pathology and Laboratory MedicineUniversity of Missouri‐Kansas City School of MedicineKansas CityMOUnited States
| | - Devika Kapuria
- Pathology and Laboratory MedicineUniversity of Missouri‐Kansas City School of MedicineKansas CityMOUnited States
| | - Agostino Molteni
- Pathology and Laboratory MedicineUniversity of Missouri‐Kansas City School of MedicineKansas CityMOUnited States
| |
Collapse
|
28
|
Fletcher A, Raza F, Buursma J, Livingston S, Kearn D, Herndon B, Vanden Heauvel G, Baybutt R, Molteni A. Pathological Changes in the Heart of the Strain CUX1 Transgenic Mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.lb432] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A Fletcher
- PathologyUniversity of Missouri Kansas City School of MedicineKansas CityMissouriUnited States
| | - F Raza
- PathologyUniversity of Missouri Kansas City School of MedicineKansas CityMissouriUnited States
| | - J Buursma
- Nutrition and Health Sciences Wheaton CollegeWheatonIllinoisUnited States
| | - S Livingston
- Nutrition and Health Sciences Wheaton CollegeWheatonIllinoisUnited States
| | - D Kearn
- Nutrition and Health Sciences Wheaton CollegeWheatonIllinoisUnited States
| | - B Herndon
- PathologyUniversity of Missouri Kansas City School of MedicineKansas CityMissouriUnited States
| | - G Vanden Heauvel
- MedicineWestern Michigan University School of MedicineKalamazooMichiganUnited States
| | - R Baybutt
- Nutrition and Health Sciences Wheaton CollegeWheatonIllinoisUnited States
| | - A Molteni
- PathologyUniversity of Missouri Kansas City School of MedicineKansas CityMissouriUnited States
| |
Collapse
|
29
|
Kesh S, Buursma J, Livingston S, Kearn D, Dasari S, Herndon B, Vanden Heuvel G, Baybutt R, Molteni A. Smooth Muscle Actin (SMA1) Stain Lungs and Heart on a Strain of CUX‐1 Transgenic mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.lb439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Susamita Kesh
- PathologyUniversity of Medicine Kansas City School of MedicineKansas CityMissouriUnited States
| | - Julie Buursma
- NutritionWheaton CollegeWheatonIllinoisUnited States
| | - S Livingston
- NutritionWheaton CollegeWheatonIllinoisUnited States
| | - Don Kearn
- NutritionWheaton CollegeWheatonIllinoisUnited States
| | - Supriya Dasari
- PathologyUniversity of Medicine Kansas City School of MedicineKansas CityMissouriUnited States
| | - Betty Herndon
- PathologyUniversity of Medicine Kansas City School of MedicineKansas CityMissouriUnited States
| | | | | | - Agostino Molteni
- PathologyUniversity of Medicine Kansas City School of MedicineKansas CityMissouriUnited States
| |
Collapse
|
30
|
Hsiung I, Qin C, Poisner A, Herndon B, Quinn T, Molteni A. Renal Effect of Triolein in a Rat Model of Fat Embolism Syndrome. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.927.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ingrid Hsiung
- PathologyUniversity of Missouri at Kansas CityKansas CityMissouriUnited States
| | - Chang Qin
- PathologyUniversity of Missouri at Kansas CityKansas CityMissouriUnited States
| | - Alan Poisner
- PharmacologyUniversity of KansasKansas CityKansasUnited States
| | - Betty Herndon
- PathologyUniversity of Missouri at Kansas CityKansas CityMissouriUnited States
| | - Timothy Quinn
- PathologyUniversity of Missouri at Kansas CityKansas CityMissouriUnited States
| | - Agostino Molteni
- PathologyUniversity of Missouri at Kansas CityKansas CityMissouriUnited States
| |
Collapse
|
31
|
Helgeson S, Harris E, Herndon B, Vanden Heuvel G, Baybutt R, Molteni A. Incidence of Pulmonary Fibrosis in Lungs of CUX‐1 Transgenic Mice. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.411.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Scott Helgeson
- School of MedicineUniversity of Missouri ‐ Kansas CityKansas CityMissouriUnited States
| | - Ethan Harris
- Applied Health Science/BiologyWheaton CollegeWheatonIllinoisUnited States
| | - Betty Herndon
- School of MedicineUniversity of Missouri ‐ Kansas CityKansas CityMissouriUnited States
| | | | - Richard Baybutt
- Applied Health Science/BiologyWheaton CollegeWheatonIllinoisUnited States
| | - Agostino Molteni
- School of MedicineUniversity of Missouri ‐ Kansas CityKansas CityMissouriUnited States
| |
Collapse
|
32
|
Pelizzari A, Ferrero D, Molteni A, Allione B, Mezzabotta M, Clavio M, Borlenghi E, Rossi G, Masiera E, Santini V. 110 BIOSIMILAR EPOETIN ZETA FOR THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS). Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30111-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Naji D, Alqalyoobi S, Herndon B, Molteni A, Salzman G. Cardiac Damage in a Model of Pulmonary Fat Embolism. Chest 2014. [DOI: 10.1378/chest.1995023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
34
|
Alqalyoobi S, Naji D, Bass D, Herndon B, Molteni A, Salzman G. Angiotensin II Receptor Blocker Interrupts Persisting Lung Damage After Long Bone Trauma. Chest 2014. [DOI: 10.1378/chest.1990668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
35
|
Centis E, Trento M, Dei Cas A, Pontiroli AE, De Feo P, Bruno A, Sasdelli AS, Arturi F, Strollo F, Vigili De' Kreutzenberg S, Invitti C, Di Bonito P, Di Mauro M, Pugliese G, Molteni A, Marchesini G. Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. Acta Diabetol 2014; 51:559-66. [PMID: 24442514 DOI: 10.1007/s00592-013-0551-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2013] [Accepted: 12/19/2013] [Indexed: 10/25/2022]
Abstract
Lifestyle changes to healthy diet (HD) and habitual physical activity (HPA) are recommended in type 2 diabetes mellitus (T2DM). Yet, for most people with diabetes, it may be difficult to start changing. We investigated the stage of change toward healthier lifestyles according to Prochaska's model, and the associated psychological factors in T2DM patients, as a prerequisite to improve strategies to implement behavior changes in the population. A total of 1,353 consecutive outpatients with T2DM attending 14 tertiary centers for diabetes treatment completed the validated EMME-3 questionnaire, consisting of two parallel sets of instruments to define the stage of change for HD and HPA, respectively. Logistic regression was used to determine the factors associated with stages that may hinder behavioral changes. A stage of change favoring progress to healthier behaviors was more common in the area of HD than in HPA, with higher scores in action and maintenance. Differences were observed in relation to gender, age and duration of disease. After adjustment for confounders, resistance to change toward HD was associated with higher body mass index (BMI) (odds ratio (OR) 1.05; 95 % confidence interval (CI) 1.02-1.08). Resistance to improve HPA also increased with BMI (OR 1.06; 95 % CI 1.03-1.10) and decreased with education level (OR 0.74; 95 % CI 0.64-0.92). Changing lifestyle, particularly in the area of HPA, is not perceived as an essential part of treatment by many subjects with T2DM. This evidence must be considered when planning behavioral programs, and specific interventions are needed to promote adherence to HPA.
Collapse
Affiliation(s)
- E Centis
- Unit of Metabolic Diseases and Clinical Dietetics, Alma Mater University of Bologna, Policlinico S. Orsola, Via Massarenti, 9, 40138, Bologna, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Likhitsup A, Herndon B, Nachnani J, Alba L, Quinn T, Torres‐Romero L, Molteni A. Pancreatic damage in obese mice with liver steatosis: effects of Ω 3 fatty acid (909.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.909.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Betty Herndon
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | | - Laura Alba
- Gastroenterology/Hepatology Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Tim Quinn
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | | | |
Collapse
|
37
|
Voelkel J, Harvey J, Adams J, Lassiter R, Stark M, Molteni A. FGF and Notch signaling hierarchy in sensory neurogenesis (651.18). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.651.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Jacob Voelkel
- Pathology University of Missouri‐ KANSAS CITY School of MedicineKANSAS CITYMOUnited States
| | - Jamison Harvey
- physiology and Developmental Biology brigham Young UniversityProvoUTUnited States
| | - Jason Adams
- physiology and Developmental Biology brigham Young UniversityProvoUTUnited States
| | - Rhonda Lassiter
- physiology and Developmental Biology brigham Young UniversityProvoUTUnited States
| | - Michael Stark
- physiology and Developmental Biology brigham Young UniversityProvoUTUnited States
| | - Agostino Molteni
- Pathology University of Missouri‐ KANSAS CITY School of MedicineKANSAS CITYMOUnited States
| |
Collapse
|
38
|
Poisner A, Herndon B, Bass D, Jain A, Fletcher A, Molteni A. Losartan protects the lung from chronic cellular damage induced by fat embolism (LB512). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.lb512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Alan Poisner
- Pharmacology Univ.of Kansas Medical CenterKANSAS CITYKSUnited States
| | - Betty Herndon
- Univ MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Devin Bass
- Univ MO KANSAS CITY School of MedKANSAS CITYMOUnited States
| | - Ashwin Jain
- Univ MO KANSAS CITY School of MedicineKANSAS CITYMOUnited States
| | | | | |
Collapse
|
39
|
Molteni A, Saeed A, Glazyrin A, Pennington V, Gawlik M, Saeed A, Quinn T, Herndon B. Examining the carcinogenic potential of pancreatic inflammation in obese mice with maspin staining (1047.10). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.1047.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Anwaar Saeed
- Hematology/oncologyKansas University School of MedWestwoodKSUnited States
| | | | | | - Mariah Gawlik
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Ali Saeed
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Tim Quinn
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Betty Herndon
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| |
Collapse
|
40
|
Harris E, Andres E, Jang I, Petrie A, Doo C, Safavi S, Herndon B, Vanden Heuvel G, Molteni A, Baybutt R. Pathological changes in the lungs of Cux1 transgenic mice (834.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.834.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ethan Harris
- Applied Health Science / Biology Wheaton College (IL)WheatonILUnited States
| | - Erica Andres
- Applied Health Science / Biology Wheaton College (IL)WheatonILUnited States
| | - Inae Jang
- Applied Health Science / Biology Wheaton College (IL)WheatonILUnited States
| | - Alex Petrie
- Applied Health Science / Biology Wheaton College (IL)WheatonILUnited States
| | - Caroline Doo
- School of Medicine University of Missouri ‐ KANSAS CITYKansas CityMOUnited States
| | - Sahar Safavi
- School of Medicine University of Missouri ‐ KANSAS CITYKansas CityMOUnited States
| | - Betty Herndon
- School of Medicine University of Missouri ‐ KANSAS CITYKansas CityMOUnited States
| | - Gregory Vanden Heuvel
- School of Medicine Western Michigan UniversityKalamazooMIUnited States
- Applied Health Science / Biology Wheaton College (IL)WheatonILUnited States
| | - Agostino Molteni
- School of Medicine University of Missouri ‐ KANSAS CITYKansas CityMOUnited States
| | - Richard Baybutt
- Applied Health Science / Biology Wheaton College (IL)WheatonILUnited States
| |
Collapse
|
41
|
Ajemba O, Zia H, Lankachandra K, Singh G, Poisner A, Herndon B, Molteni A. Pulmonary histopathology of a case of fat embolism (FE) in a patient and its similarity to an animal model of FE (834.11). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.834.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ogugua Ajemba
- Pathology Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Hamid Zia
- Pathology Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | | - Gurmukh Singh
- Pathology Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | | - Betty Herndon
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Agostino Molteni
- Pathology Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| |
Collapse
|
42
|
Likhitsup A, Alba L, Herndon B, Mansour A, Zia H, Molteni A. Histology of liver oxidative stress in an obese mouse model of nonalcoholic fatty liver disease treated with Ω3 fatty acids, TNFα‐receptor blocker, or curcumin (1116.1). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.1116.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Laura Alba
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Betty Herndon
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Ahmad Mansour
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Hamid Zia
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | |
Collapse
|
43
|
Fotouhi A, Fotouhi A, Boyer D, Herndon B, Quinn T, Molteni A. Nanoparticles in lungs: a model of effects after infection (406.3). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.406.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ariana Fotouhi
- LabM3‐202 Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Anna Fotouhi
- LabM3‐202 Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Daniella Boyer
- Kansas City Univ of Medicine & Bioscience Kansas CityMOUnited States
| | - Betty Herndon
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Tim Quinn
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | |
Collapse
|
44
|
Kesh S, Molteni A, Stevens T, Herndon B. The pulmonary vessel adventitia: role in the pathology of fat embolism (LB511). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.lb511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Susamita Kesh
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | | | - Todd Stevens
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| | - Betty Herndon
- Univ.MO‐Kansas City School of MedKANSAS CITYMOUnited States
| |
Collapse
|
45
|
Alkhazna A, Saeed A, Herndon B, Hilal A, Quinn T, Molteni A, Salzman G. The Renin-Angiotensin System [RAS] in Fat Embolism-Induced Lung Pathology. Chest 2013. [DOI: 10.1378/chest.1703841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
46
|
Al Hariri A, Herndon B, Molteni A. Resistin: The Link From Fatty Inflammation to Macrophages. Chest 2013. [DOI: 10.1378/chest.1704483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
47
|
|
48
|
Oliva E, Santini V, Zini G, Palumbo G, Poloni A, Cortelezzi A, Rodeghiero F, Voso M, Molteni A, Sanpaolo G, Liberati M, Morabito F, Balleari E, Impera S, Salvi F, Spiriti MA, Marino A, Rodà F, Alati C, Ronco F, Di Raimondo F, Leoni P, Alimena G, Latagliata R, Nobile F. P-310 Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70357-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Molteni A, Riva M, Ravano E, Greco R, Cesana C, Scarpati B, Morra E. P-099 The prognostic significance of the immunocytometric blast counts in MDS patients with medullar blasts <5% at the optical evaluation. Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70147-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Molteni A, Torres‐Romero L, Black E, Friedrich J, Tanner JC, Poisner A, Herndon B. Fat Embolism Syndrome Following Bone Fracture May Be Exacerbated By LPS. FASEB J 2013. [DOI: 10.1096/fasebj.27.1_supplement.254.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|